Log Out

US Stock MarketDetailed Quotes

VIGL Vigil Neuroscience

Watchlist

3.160
-0.060-1.86%

Close Apr 15 16:00 ET

3.160
0.0000.00%

Post 16:02 ET

116.56MMarket Cap-1483P/E (TTM)

Vigil Neuroscience Stock Forum

Sign in to post a comment

Dr. Kaufmann's appointment, with her vast experience in neurological and rare diseases, is anticipated to benefit Vigil as it progresses the development of its drugs iluzanebart and VG-3927. Her expertise in both domestic and global drug development is considered a valuable asset for the company.

Press Release: Vigil Neuroscience Appoints Petra Kaufmann, M.D., as Chief Medical Officer

1

Sep 26, 2023 08:03

Support

$Vigil Neuroscience(VIGL.US)$ Jumped in at 5.10. Finally getting the hang of catching winners. @AmyNic @Biff @Den the Dragon @Firebird (Trixie)@GAME_DAY @Gman511 @iamiam @jimmy the trader @Jenna Ragan @Mcsnacks H Tupack @Megadad2186 @MangoXXX @MooMamaLlama @Ripper @Rivera @StockVader

4

1

Aug 26, 2022 13:09

Very low volume, but I like the setup. I'm going to throw a little something on this one and keep a close eye on it.

$Vigil Neuroscience(VIGL.US)$

3

1

Moomoo IPO Buzz

Jan 4, 2022 04:43

ColumnsIPO Buzz | 2022 IPO market kicks off with 3 biotechs set to trade on Friday

$Amylyx Pharmaceuticals(AMLX.US)$$CinCor Pharma, Inc.(CINC.US)$$Vigil Neuroscience(VIGL.US)$

IPO Buzz | 2022 IPO market kicks off with 3 biotechs set to trade on Friday

Expand

Stocks & Markets Analysis

55

6

No comment yet

Analysis

Analyst Rating

No Data

Price Target

No Data

US

Overall